CML: Asciminib Bests Standard TKIs as Frontline Therapy
Asciminib demonstrated efficacy vs standard-of-care frontline TKIs in newly diagnosed patients with CML.
Stay updated with breaking news from Eunice Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Asciminib demonstrated efficacy vs standard-of-care frontline TKIs in newly diagnosed patients with CML.
New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park
Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very p
Up to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene mutation, which is associated with a high risk of relapse and a very p
For the last 8 years, the Jacquie Hirsch For All Foundation has donated gift cards to families of patients at Roswell Park Comprehensive Cancer Center.